-
Signature
-
/s/ Jonathan V. Dixon, Attorney-in-Fact
-
Issuer symbol
-
BNGO
-
Transactions as of
-
03 Jun 2025
-
Net transactions value
-
-$99.63
-
Form type
-
4
-
Filing time
-
03 Jun 2025, 18:59:01 UTC
Quoteable Key Fact
"Mark Oldakowski filed Form 4 for Bionano Genomics, Inc. (BNGO) on 03 Jun 2025."
Quick Takeaways
- This page summarizes Mark Oldakowski's Form 4 filing for Bionano Genomics, Inc. (BNGO).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 03 Jun 2025, 18:59.
What Changed
- Previous filing in this sequence was filed on 18 Mar 2025.
- Current net transaction value: -$99.63.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| OLDAKOWSKI MARK |
Chief Operating Officer |
C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO |
/s/ Jonathan V. Dixon, Attorney-in-Fact |
03 Jun 2025 |
0001745566 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BNGO |
Common Stock |
Tax liability |
$99.63 |
-27 |
-2.7% |
$3.69 |
974 |
03 Jun 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: